Metraipolis › archive › dc_23c336f66cb2

Assessing the Oncological Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis — Europe PMC PMID:41356998

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41356998
DOI
10.7759/cureus.96071
License (as archived)
solo-consultazione
Archived
2026-11-08T19:33:45.650Z
SHA-256 of the archived text
3b1c48ccc7d521acff8051706aeff2bed73eec52dd79173d7350f661208c359b
Stable URL of this page
https://metraipolis.com/documento/dc_23c336f66cb2

How to cite

Assessing the Oncological Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis — Europe PMC PMID:41356998 — Europe PMC (en), https://europepmc.org/article/MED/41356998 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_23c336f66cb2 (Metraipolis archive dc_23c336f66cb2, sha256 3b1c48ccc7d521acff8051706aeff2bed73eec52dd79173d7350f661208c359b)
BibTeX
@misc{dc23c336f66cb2,
  title = {Assessing the Oncological Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis — Europe PMC PMID:41356998},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41356998},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_23c336f66cb2; sha256 3b1c48ccc7d521acff8051706aeff2bed73eec52dd79173d7350f661208c359b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41356998. Agents can read the archived copy with the MCP tool read_document.